D.E. Shaw & Co
BTMD icon

D.E. Shaw & Co’s Biote Corp BTMD Stock Holding History

D.E. Shaw & Co’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-392,700
Closed -$3.88M – 5357
2022
Q1 		$3.88M Sell
392,700
-114,100
-23% -$1.12M ﹤0.01% 2612
2021
Q4 		$4.98M Buy
506,800
+38,941
+8% +$380K ﹤0.01% 2383
2021
Q3 		$4.56M Buy
467,859
+442,859
+1,771% +$4.29M ﹤0.01% 2193
2021
Q2 		$243K Buy
+25,000
New +$245K ﹤0.01% 4372

Other funds holding BTMD

CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return

D.E. Shaw & Co's BTMD Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 392,700 shares — an estimated $3.88M sold.

D.E. Shaw & Co first reported a position in BTMD in Q2 2021 and held it in 4 quarters. The position peaked at $4.98M in Q4 2021. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 392,700 Biote Corp shares in Q2 2022, an estimated $3.88M.
  • D.E. Shaw & Co first reported a position in Biote Corp in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Biote Corp position peaked at $4.98M in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.